US Patent Issued to Zetagen Therapeutics on Oct. 20 for "Polysilane methacrylic compounds, methods of making them and their uses, including for the treatment of cancer" (New York Inventor)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,165, issued on Oct. 20, was assigned to Zetagen Therapeutics Inc. (Syracuse, N.Y.).

"Polysilane methacrylic compounds, methods of making them and their uses, including for the treatment of cancer" was invented by Bryan S. Margulies (Liverpool, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A polysilane methacrylic polymer and processes of preparing the polysilane methacrylic polymer are provided."

The patent was filed on Sept. 18, 2024, under Application No. 18/888,673.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch...